Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Influenza and RSV incidence during COVID-19 pandemic—an observational study from in-hospital point-of-care testing

Open access

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has forced the implementation of unprecedented public health measures strategies which might also have a significant impact on the spreading of other viral pathogens such as influenza and Respiratory Syncytial Virus (RSV) . The present study compares the incidences of the most relevant respiratory viruses before and during the SARS-CoV-2 pandemic in emergency room patients. We analyzed the results of in total 14,946 polymerase chain reaction point-of-care tests (POCT-PCR) for Influenza A, Influenza B, RSV and SARS-CoV-2 in an adult and a pediatric emergency room between December 1, 2018 and March 31, 2021. Despite a fivefold increase in the number of tests performed, the positivity rate for Influenza A dropped from 19.32% (165 positives of 854 tests in 2018/19), 14.57% (149 positives of 1023 in 2019–20) to 0% (0 positives of 4915 tests) in 2020/21. In analogy, the positivity rate for Influenza B and RSV dropped from 0.35 to 1.47%, respectively, 10.65–21.08% to 0% for both in 2020/21. The positivity rate for SARS-CoV2 reached 9.74% (110 of 1129 tests performed) during the so-called second wave in December 2020. Compared to the two previous years, seasonal influenza and RSV incidence was eliminated during the COVID-19 pandemic. Corona-related measures and human behavior patterns could lead to a significant decline or even complete suppression of other respiratory viruses such as influenza and RSV.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00430-021-00720-7

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Instrument, cartridge and scheme of the POCT-PCR testing. A POCT-PCR workstation with GeneXpert XVI-16 module instrument (left) and GeneXpert Xpress Software on a desktop computer (right). B Xpert Xpress Cartridge for Quadruple-POCT-PCR test. C Schematic representation of the respective test strategy from December 2018 to March 2021
Fig. 1 Instrument, cartridge and scheme of the POCT-PCR testing. A POCT-PCR workstation with GeneXpert XVI-16 module instrument (left) and GeneXpert Xpress Software on a desktop computer (right). B Xpert Xpress Cartridge for Quadruple-POCT-PCR test. C Schematic representation of the respective test strategy from December 2018 to March 2021CC BY · PubMed Central
Fig. 2 POCT-PCR tests for SARS-COV-2 from May 2020 to February 2021. A The number of POCT-PCR tests for SARS-COV-2 performed monthly increased until November 2020 and then stayed stable around 1200 total tests per month. B During the so-called second SARS-CoV-2 wave, the positive test rate increased from September 2020 and reached its maximum in December 2020 with a subsequent decrease
Fig. 2 POCT-PCR tests for SARS-COV-2 from May 2020 to February 2021. A The number of POCT-PCR tests for SARS-COV-2 performed monthly increased until November 2020 and then stayed stable around 1200 total tests per month. B During the so-called second SARS-CoV-2 wave, the positive test rate increased from September 2020 and reached its maximum in December 2020 with a subsequent decreaseCC BY · PubMed Central
Fig. 3 POCT-PCR tests for Influenza A, Influenza B and RSV from 2018 to 2021. A The total number of seasonal POCT-PCR tests for Influenza A, Influenza B and RSV was roughly the same in the 2018/19 and 2019/20 seasons and increased by fivefold in 2020/21. B–D The number of positive tests for Influenza and RSV in the 2018/19 and 2019/20 seasons completely disappeared in 2020/21
Fig. 3 POCT-PCR tests for Influenza A, Influenza B and RSV from 2018 to 2021. A The total number of seasonal POCT-PCR tests for Influenza A, Influenza B and RSV was roughly the same in the 2018/19 and 2019/20 seasons and increased by fivefold in 2020/21. B–D The number of positive tests for Influenza and RSV in the 2018/19 and 2019/20 seasons completely disappeared in 2020/21CC BY · PubMed Central
Fig. 4 Overall positive POCT-PCR tests 2018–2021. During the COVID-19 pandemic, Influenza and RSV infections disappeared when compared to previous seasons
Fig. 4 Overall positive POCT-PCR tests 2018–2021. During the COVID-19 pandemic, Influenza and RSV infections disappeared when compared to previous seasonsCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Cited by

See all 82

Metadata

Authors
Stamm, P., Sagoschen, I., Weise, K., Plachter, B., Münzel, T., Gori, T., & Vosseler, M.
Affiliations
University Medical Center of the Johannes Gutenberg University Mainz (DE)
Corresponding author
Stamm, Paul
Venue
Medical Microbiology and Immunology
Published
2021-10-04
Volume
210
Issue
5-6
Pages
277-282
ISSN
  • 0044-3077 (ISSN-L)
  • 0300-8584
  • 1432-1831
OpenAlex
W3203240491
Cited by
82
References
28
Citations by year
2026: 3 · 2025: 14 · 2024: 25 · 2023: 22 · 2022: 18
FWCI
11.71
Type
journal article
Language
en
Open access
Licence
Locations
  • Medical Microbiology and Immunology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion, cc-by)
  • Gutenberg Open Science (submittedVersion, cc-by-nd)
  • Gutenberg Open Science (cc-by)
Funders
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Topics
  • Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
  • Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Keywords
COVID-19 pandemic, influenza A virus, influenza B, respiratory syncytial virus, SARS-CoV-2, emergency department patients, positivity rate, public health measures, pediatric patients
MeSH terms
Point-of-Care Testing, COVID-19, Hospitals, Humans, Influenza, Human, Orthomyxoviridae, Retrospective Studies, Incidence, Polymerase Chain Reaction, Respiratory Syncytial Virus, Human, Respiratory Syncytial Virus Infections, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Influenza and RSV incidence during COVID-19 pandemic—an observational study from in-hospital point-of-care testing. https://app.cochat.ai/papers/10.1007/s00430-021-00720-7
The paper
Stamm, P., Sagoschen, I., Weise, K., Plachter, B., Münzel, T., Gori, T., & Vosseler, M. (2021). Influenza and RSV incidence during COVID-19 pandemic—an observational study from in-hospital point-of-care testing. Medical Microbiology and Immunology. https://doi.org/10.1007/s00430-021-00720-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.